Lilly’s Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study

Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study

Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage ​study.

Lilly’s Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study

Feb 18 (Reuters) – Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients ​with the skin disease and obesity in ‌a late-stage study, compared to Taltz alone. The drugs showed greater improvement in skin symptoms and weight loss in the study that had 274 patients. About 27.1% of patients who ‌had ​received Taltz and Zepbound reached ⁠complete skin clearance and ⁠at least …

Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results

🤝 Lilly's Zepbound plus Taltz combo: The company said the drugs, when taken together, helped 27.1% of patients with plaque psoriasis and obesity (or who were overweight) achieve full skin clearance ...